Mylan N.V. was a global generic and specialty pharmaceuticals company. In November 2020, Mylan merged with Upjohn, Pfizer's off-patent medicine division, to form Viatris. [2] Previously, the company was domiciled in the Netherlands, with principal executive offices in Hatfield, Hertfordshire, UK [3] and a "Global Center" in Canonsburg ...

Mylan is now part of Viatris, a new global healthcare company committed to empowering people to live healthier at every stage of life. We encourage you to learn more about our commitment to increasing access to quality medicines for patients when and where they need them.

Nov 12, 2019 · HERTFORDSHIRE, England & PITTSBURGH & Mylan N.V. (NASDAQ: MYL) and Pfizer Inc. (NYSE: PFE) today announced that the name of the new company to be formed by the planned combination of Mylan and Upjohn, a division …

In 1972, Milan changed its name to Mylan Laboratories as a way to highlight its technical expertise and to make it easier for investors to find the company at the end of the fine-print stock listings in newspapers after the first shares of Mylan …

Viatris Inc. is an American global pharmaceutical and healthcare corporation headquartered in Canonsburg, Pennsylvania. The corporation was formed through the merger of Mylan and Upjohn, a legacy division of Pfizer, on November 16, 2020. [2]

Mylan has one of the most comprehensive and diverse biosimilar programs in the industry, with 20 biosimilar and insulin analog products on the market or in our global pipeline focused on the areas of oncology, immunology, endocrinology, dermatology and ophthalmology.

Mylan N.V. and Pfizer Inc concluded a global transaction combining Mylan N.V. and Upjohn (Pfizer’s off-patent branded and generic established medicines business) to create a new pharmaceutical company called Viatris Inc in 2020.

Mylan | 472,458 followers on LinkedIn. Follow us on our new journey as Viatris. www.linkedin.com/company/viatris | We have combined with Upjohn, a legacy division of Pfizer, and are now Viatris.

Oct 30, 2020 · The Investor Relations website contains information about Mylan N.V.'s business for stockholders, potential investors, and financial analysts.

Nov 16, 2020 · NEW YORK-- (BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) announced today that it has completed the transaction to spin off its Upjohn Business and combine it with Mylan N.V. to form Viatris Inc.